Metabolomic and gut microbial biomarkers of smoking cessation treatment in long-term drug therapy
A study protocol for a randomized controlled trial
Bibliographic Data
https://clinicaltrials.gov/study/NCT06803706?cond=metabolomic%20and%20microbial%20biomarkers%20in%20smoking%20cessation&rank=1, identifier NCT06803706
Clinical trial · Drug · Gut flora · Metabolomics · Microbiome · Mood · Mood disorders · Nicotine · Randomized controlled trial · Smoking cessation · Gut microbiota and health · Metabolomics and Mass Spectrometry Studies · Tryptophan and brain disorders
Addressing the burden of mental, neurological, and substance use disorders
Determinants of Tobacco Use and Renaming the FTND to the Fagerstrom Test for Cigarette Dependence
Addiction Motivation Reformulated
Change in mental health after smoking cessation
Sex and gender differences in substance use disorders
Dada2
G*Power 3
Fitting Linear Mixed-Effects Models Using lme4
The Therapeutic Community
The Metabolic Factor Kynurenic Acid of Kynurenine Pathway Predicts Major Depressive Disorder
The great decline in adolescent cigarette smoking since 2000
Evolution of the global smoking epidemic over the past half century
Staff Smoking and Other Barriers to Nicotine Dependence Intervention in Addiction Treatment Settings
| Citation velocity | historical |
|---|---|
| Highly cited | No |